clinical info.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Interim Guidance for Covid-19 and Persons with HIV is now available.

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.

Glossary

Medical dictionary of HIV-related terms.

Resources

HIV-related resources from the National Institutes of Health.

Mobile Application

The Clinical Info mobile application gives access to federally approved treatment and research information for HIV and AIDS, optimized for mobile devices free of charge.

Download the beta version of the Clinical Info App for your iOS or Android device.

Appendix 3. Financial Disclosures

Read more about Appendix 3. Financial Disclosures

Appendix 2. Panel Members

Read more about Appendix 2. Panel Members

Appendix 1. Important Guideline Considerations

Read more about Appendix 1. Important Guideline Considerations

Reproductive Options for Couples When One or Both Partners Have HIV

Read more about Reproductive Options for Couples When One or Both Partners Have HIV

Overview

Read more about Overview

Table 6. Common or Serious Adverse Reactions Associated with Systemically Administered Drugs Used to Treat Opportunistic Infections

Read more about Table 6. Common or Serious Adverse Reactions Associated with Systemically Administered Drugs Used to Treat Opportunistic Infections

Table 5. Significant Pharmacokinetic Interactions between Drugs Used to Treat or Prevent Opportunistic Infections

Read more about Table 5. Significant Pharmacokinetic Interactions between Drugs Used to Treat or Prevent Opportunistic Infections

Table 4. Indications for Discontinuing and Restarting Opportunistic Infection Prophylaxis in HIV-Infected Adults and Adolescents

Read more about Table 4. Indications for Discontinuing and Restarting Opportunistic Infection Prophylaxis in HIV-Infected Adults and Adolescents

Table 3. Dosing Recommendations for Anti-TB Drugs for Treatment of Active Drug Sensitive TB

Read more about Table 3. Dosing Recommendations for Anti-TB Drugs for Treatment of Active Drug Sensitive TB

Table 2. Treatment of AIDS-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)

Read more about Table 2. Treatment of AIDS-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)